يعرض 1 - 10 نتائج من 23 نتيجة بحث عن '"Kwan, EM"', وقت الاستعلام: 1.41s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    العلاقة: pii: BCO2129; Anton, A., Pillai, S., Semira, M. C., Wong, S., Shapiro, J., Weickhardt, A., Azad, A., Kwan, E. M., Spain, L., Gunjur, A., Torres, J., Parente, P., Parnis, F., Goh, J., Baenziger, O., Gibbs, P. & Tran, B. (2022). Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer. BJUI Compass, 3 (3), pp.205-213. https://doi.org/10.1002/bco2.129Test.; http://hdl.handle.net/11343/308089Test

  4. 4
    دورية أكاديمية

    العلاقة: NHMRC/1098647; pii: 10.1186/s12916-022-02298-0; Mak, B., Lin, H. -M., Kwan, E. M., Fettke, H., Ben, T., Davis, I. D., Mahon, K., Stockler, M. R., Briscoe, K., Marx, G., Zhang, A., Crumbaker, M., Tan, W., Huynh, K., Meikle, T. G., Mellett, N. A., Hoy, A. J., Du, P., Yu, J. ,. Horvath, L. G. (2022). Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer. BMC MEDICINE, 20 (1), https://doi.org/10.1186/s12916-022-02298-0Test.; http://hdl.handle.net/11343/307138Test

  5. 5
    دورية أكاديمية

    العلاقة: pii: jnumed.121.262552; Pathmanandavel, S., Crumbaker, M., Yam, A. O., Nguyen, A., Rofe, C., Hovey, E., Gedye, C., Kwan, E. M., Hauser, C., Azad, A. A., Eu, P., Martin, A. J., Joshua, A. M. & Emmett, L. (2022). 177 Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN) Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial. JOURNAL OF NUCLEAR MEDICINE, 63 (4), pp.560-566. https://doi.org/10.2967/jnumed.121.262552Test.; http://hdl.handle.net/11343/304962Test

  6. 6
    دورية أكاديمية

    العلاقة: NHMRC/1098647; pii: tau-10-04-1688; Kwan, E. M., Fettke, H., Crumbaker, M., Docanto, M. M., To, S. Q., Bukczynska, P., Mant, A., Ng, N., Foroughi, S., Graham, L. -J. K., Haynes, A. -M., Azer, S., Lim, L. E., Segelov, E., Mahon, K., Davis, I. D., Parente, P., Pezaro, C., Todenhofer, T. ,. Azad, A. A. (2021). Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer. TRANSLATIONAL ANDROLOGY AND UROLOGY, 10 (4), https://doi.org/10.21037/tau-20-1444Test.; http://hdl.handle.net/11343/280606Test

  7. 7
    دورية أكاديمية

    العلاقة: NHMRC/1098647; pii: S2352-3964(21)00418-7; Lin, H. -M., Mak, B., Yeung, N., Huynh, K., Meikle, T. G., Mellett, N. A., Kwan, E. M., Fettke, H., Tran, B., Davis, I. D., Mahon, K. L., Zhang, A., Stockler, M. R., Briscoe, K., Marx, G., Crumbaker, M., Stricker, P. D., Du, P., Yu, J. ,. Horvath, L. G. (2021). Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase. EBIOMEDICINE, 72, https://doi.org/10.1016/j.ebiom.2021.103625Test.; http://hdl.handle.net/11343/296738Test

  8. 8
    دورية أكاديمية

    العلاقة: NHMRC/1090204; pii: 10.1038/s41467-021-25175-5; Risbridger, G. P., Clark, A. K., Porter, L. H., Toivanen, R., Bakshi, A., Lister, N. L., Pook, D., Pezaro, C. J., Sandhu, S., Keerthikumar, S., Urban, R. Q., Papargiris, M., Kraska, J., Madsen, H. B., Wang, H., Richards, M. G., Niranjan, B., O'Dea, S., Teng, L. ,. Taylor, R. A. (2021). The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology. NATURE COMMUNICATIONS, 12 (1), https://doi.org/10.1038/s41467-021-25175-5Test.; http://hdl.handle.net/11343/287772Test

  9. 9
    دورية أكاديمية

    العلاقة: pii: cancers13194964; Lin, H. -M., Yeung, N., Hastings, J. F., Croucher, D. R., Huynh, K., Meikle, T. G., Mellett, N. A., Kwan, E. M., Davis, I. D., Tran, B., Mahon, K. L., Zhang, A., Stockler, M. R., Briscoe, K., Marx, G., Bastick, P., Crumbaker, M. L., Joshua, A. M., Azad, A. A. ,. Horvath, L. G. (2021). Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer. CANCERS, 13 (19), https://doi.org/10.3390/cancers13194964Test.; http://hdl.handle.net/11343/296812Test

  10. 10
    دورية أكاديمية

    العلاقة: pii: 10.1186/s13073-020-00770-1; Lau, E., McCoy, P., Reeves, F., Chow, K., Clarkson, M., Kwan, E. M., Packwood, K., Northen, H., He, M., Kingsbury, Z., Mangiola, S., Kerger, M., Furrer, M. A., Crowe, H., Costello, A. J., McBride, D. J., Ross, M. T., Pope, B., Hovens, C. M. & Corcoran, N. M. (2020). Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression. GENOME MEDICINE, 12 (1), https://doi.org/10.1186/s13073-020-00770-1Test.; http://hdl.handle.net/11343/244599Test